Daycares and early childhood education programs frequently use spray sunscreen on children, but still have room for improvement when it comes to sun safety, according to a new Northwestern Medicine study.
A drug originally designed for chemotherapy may reduce allergic responses for a variety of allergens, according to a study published in the Journal of Allergy and Clinical Immunology.
A groundbreaking new wearable device developed by Northwestern scientists and designed to be worn on the throat could be a game-changer in the field of stroke rehabilitation.
A new wearable microfluidic system that monitors sweat loss and analyzes sweat chemistry, developed at Northwestern, is being brought into widespread distribution.
Patients with an advanced form of kidney cancer have similar quality of life outcomes on a therapy called cabozantinib, compared to those on a standard treatment.
Lesbian and gay youth showed significantly less psychological distress and were buffered against the negative effects of bullying and victimization when in a relationship.
Scientists throughout Feinberg are deeply invested in identifying health disparities — those differences in health outcomes between populations — as well as exploring novel interventions.
A multidisciplinary global team including two Northwestern University professors has won a $15 million grant to improve the survival of newborns in Africa.
A simple toolkit of checklists, education materials and feedback reporting improved the quality of care, but not outcomes, in a group of 60 hospitals in south India, according to a new Northwestern Medicine study.
Northwestern Medicine scientists have discovered why Huntington’s disease is so toxic to cancer cells and have harnessed it for a novel approach to treat cancer.